IP Library › Granted Patent US 11,472,911
Granted Patent B2
US 11,472,911 · App. 16/248,498 · Granted Oct 18, 2022

End-capped polyisobutylene polyurethane

Inventors: Joseph T. Delaney, Jr. (Minneapolis, MN); Andrew J. Ro (Maple Grove, MN); David R. Wulfman (Minneapolis, MN); Niraj Gurung (Sauk Rapids, MN); Patrick Willoughby (Shoreview, MN)
Assignee: Cardiac Pacemakers, Inc.
C08G18/6208A61L27/16A61L29/041A61L31/048A61L31/129A61L31/143C08G18/12C08G18/2865C08G18/4063C08G18/4808C08G18/4854C08G18/6204C08G18/7671C08G18/833
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,472,911
App. No.
16/248,498
Granted
Oct 18, 2022
Kind
B2
Abstract

A polymeric material includes a polyisobutylene-polyurethane block copolymer. The polyisobutylene-polyurethane block copolymer includes soft segments, hard segments, and end groups. The soft segments include a polyisobutylene diol residue. The hard segments include a diisocyanate residue. The end groups are bonded by urea bonds to a portion of the diisocyanate residue. The end groups include a residue of a mono-functional amine.

Claims (23)

1. A polymeric material comprising:

a polyisobutylene-polyurethane block copolymer including:

soft segments including a polyisobutylene diol residue;

hard segments including a 4,4′-methylene diphenyl and diisocyanate residue; and

end groups bonded by urea bonds to the diisocyanate residue, the end groups including a residue of butylamine.

2. The polymeric material of claim 1 , wherein the soft segments are present in the copolymer in an amount of about 40% to about 70% by weight of the copolymer, and the hard segments are present in the copolymer in an amount of about 30% to about 60% by weight of the copolymer.

3. The polymeric material of claim 1 , wherein the hard segments further include a chain extender residue.

4. The polymeric material of claim 3 , wherein the chain extender residue is 1,4-butanediol residue.

5. The polymeric material of claim 1 , wherein the soft segments further include at least one of: a polyether diol residue, a polyester diol residue, and a polycarbonate diol residue.

6. A medical device comprising:

a polymeric material including:

a polyisobutylene-polyurethane block copolymer including:

soft segments including a polyisobutylene diol residue;

hard segments including a 4,4′-methylene diphenyl diisocyanate residue; and

end groups bonded by urea bonds to the diisocyanate residue, the end groups including a residue of butylamine.

7. The medical device of claim 6 , wherein the soft segments are present in the copolymer in an amount of about 40% to about 70% by weight of the copolymer, and the hard segments are present in the copolymer in aramount of about 30% to about 60% by weight of the copolymer.

8. A method of making a polymeric material, the method comprising:

heating a mixture of soft segment components and hard segment components to an elevated temperature, the soft segment components including a polyisobutylene diol, and the hard segment components including 4,4′-methylene diphenyl diisocyanate to form a prepolymer;

reacting a chain extender with the prepolymer to form a polymer; and

reacting an end capping agent with at least one of: the prepolymer and the polymer to form the polymeric material, wherein the end capping agent is butylamine.

9. The method of claim 8 , wherein the diisocyanate is in stoichiometric excess with respect to the polyisobutylene diol and the chain extender, and the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.

10. The method of claim 8 , wherein heating the mixture of the soft segment components and the hard segment components to an elevated temperature and reacting the chain extender with the heated mixture are in the presence of a tertiary amine catalyst.

11. The method of claim 8 , wherein the soft segment components further include a polytetramethylene oxide diol, the diisocyanate is in stoichiometric excess with respect to the polyisobutylenediol, the chain extender, and the polytetramethyleneoxide diol, and the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2020
From: DELANEY, JOSEPH T., JR.; RO, ANDREW J.; WULFMAN, DAVID R.; GURUNG, NIRAJ; WILLOUGHBY, PATRICK
To: CARDIAC PACEMAKERS, INC.
Reel/Frame 054470/0422 →
Continuity (2)
Provisional Application 62618262 · Jan 17, 2018
Related Publication 20190218334A1 · Jul 18, 2019